Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 24625006)

1.

Brivaracetam for the treatment of epilepsy in adults.

Mula M.

Expert Rev Neurother. 2014 Apr;14(4):361-5. doi: 10.1586/14737175.2014.896200. Review.

PMID:
24625006
2.

Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.

Biton V, Berkovic SF, Abou-Khalil B, Sperling MR, Johnson ME, Lu S.

Epilepsia. 2014 Jan;55(1):57-66. doi: 10.1111/epi.12433. Epub 2013 Nov 8.

3.

Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial.

Kwan P, Trinka E, Van Paesschen W, Rektor I, Johnson ME, Lu S.

Epilepsia. 2014 Jan;55(1):38-46. doi: 10.1111/epi.12391. Epub 2013 Oct 3.

PMID:
24116853
4.

Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.

Ryvlin P, Werhahn KJ, Blaszczyk B, Johnson ME, Lu S.

Epilepsia. 2014 Jan;55(1):47-56. doi: 10.1111/epi.12432. Epub 2013 Oct 28.

5.

Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: a phase IIb, randomized, controlled trial.

Van Paesschen W, Hirsch E, Johnson M, Falter U, von Rosenstiel P.

Epilepsia. 2013 Jan;54(1):89-97. doi: 10.1111/j.1528-1167.2012.03598.x. Epub 2012 Jul 19.

PMID:
22813235
6.

Brivaracetam for the treatment of epilepsy.

Schulze-Bonhage A.

Expert Opin Pharmacother. 2011 Aug;12(12):1959-66. doi: 10.1517/14656566.2011.591380. Epub 2011 Jun 20. Review.

PMID:
21682662
7.

Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A.

Matagne A, Margineanu DG, Kenda B, Michel P, Klitgaard H.

Br J Pharmacol. 2008 Aug;154(8):1662-71. doi: 10.1038/bjp.2008.198. Epub 2008 May 26.

8.

Pharmacotherapy of epilepsy: newly approved and developmental agents.

Stephen LJ, Brodie MJ.

CNS Drugs. 2011 Feb;25(2):89-107. doi: 10.2165/11584860-000000000-00000. Review.

PMID:
21254787
9.

Adjunctive brivaracetam for refractory partial-onset seizures: a randomized, controlled trial.

French JA, Costantini C, Brodsky A, von Rosenstiel P; N01193 Study Group.

Neurology. 2010 Aug 10;75(6):519-25. doi: 10.1212/WNL.0b013e3181ec7f7f. Epub 2010 Jun 30.

PMID:
20592253
10.

Brivaracetam (UCB 34714).

von Rosenstiel P.

Neurotherapeutics. 2007 Jan;4(1):84-7. Review.

PMID:
17199019
11.

Brivaracetam: a new drug in development for epilepsy and neuropathic pain.

Malawska B, Kulig K.

Expert Opin Investig Drugs. 2008 Mar;17(3):361-9. doi: 10.1517/13543784.17.3.361 . Review.

PMID:
18321235
12.

Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.

Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, Mason A, Golder S, O'Meara S, Sculpher M, Drummond M, Forbes C.

Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. Review.

13.

Physiologically based pharmacokinetic/pharmacodynamic animal-to-man prediction of therapeutic dose in a model of epilepsy.

Brochot A, Zamacona M, Stockis A.

Basic Clin Pharmacol Toxicol. 2010 Mar;106(3):256-62. doi: 10.1111/j.1742-7843.2009.00536.x. Epub 2010 Jan 25. Review.

PMID:
20102365
14.

ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.

Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, Kalviainen R, Mattson R, Perucca E, Tomson T.

Epilepsia. 2006 Jul;47(7):1094-120. Review.

PMID:
16886973
15.

Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.

Trevathan E, Kerls SP, Hammer AE, Vuong A, Messenheimer JA.

Pediatrics. 2006 Aug;118(2):e371-8. Epub 2006 Jul 17.

PMID:
16847080
16.

Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: relationship to anti-convulsant properties.

Gillard M, Fuks B, Leclercq K, Matagne A.

Eur J Pharmacol. 2011 Aug 16;664(1-3):36-44. doi: 10.1016/j.ejphar.2011.04.064. Epub 2011 May 8.

PMID:
21575627
17.

Brivaracetam UCB.

Malawska B, Kulig K.

Curr Opin Investig Drugs. 2005 Jul;6(7):740-6. Review.

PMID:
16044671
18.

Anti-ictogenic and antiepileptogenic properties of brivaracetam in mature and immature rats.

Dupuis N, Matagne A, Staelens L, Dournaud P, Desnous B, Gressens P, Auvin S.

Epilepsia. 2015 May;56(5):800-5. doi: 10.1111/epi.12973. Epub 2015 Mar 25.

PMID:
25818358
19.

Spotlight on levetiracetam in epilepsy.

Lyseng-Williamson KA.

CNS Drugs. 2011 Oct 1;25(10):901-5. doi: 10.2165/11208340-000000000-00000. Review.

PMID:
21936590
20.

Pharmacological management of epilepsy: recent advances and future prospects.

Johannessen Landmark C, Johannessen SI.

Drugs. 2008;68(14):1925-39. Review.

PMID:
18778117
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk